Endovia Health Sciences, Inc. (EDVA): Unregistered Sales of Equity Securities
Endovia Health Sciences, Inc. (EDVA) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. Item 3.02 Unregistered Sales of Equity Securities. On September 30, 2026, Endovia Health Sciences, Inc. (the “Company”) sold and issued a total of 526,582 shares of common stock pursuant to that certain Securities Purchase Agreement dated September 19, 2025 with C/M Capital Maste
How this was made
The 30-second read
Why it matters
The disclosed capital raise is modest and unlikely to move the stock materially.
Market read
Primary disclosure of a small private placement; limited trading relevance.
What to watch
Potential future dilution if more unregistered placements occur.
Background
SEC Form 8‑K filings are primary sources for corporate actions. This filing reports a private placement under Rule 506(b).
Ticker impact
Endovia Health Sciences disclosed an unregistered sale of 526,582 shares for $81,830.84 in an 8‑K filing.
minimal pressure as the market absorbs a modest capital raise
The raise amount is trivial relative to typical market caps; investors are unlikely to adjust positions.
Market effects
None significant; the transaction is company‑specific.
No broader regional effect.
Limited to Endovia shareholders.
Counterpoint
If the company is seeking cash for urgent needs, the small raise could signal liquidity concerns.
Key entities
- companyEndovia Health Sciences, Inc.
Biopharma company issuing unregistered equity.
- investorC/M Capital Master Fund, LP
Purchaser of the private placement.
